Literature DB >> 19337062

Increasing incidence and decreasing mortality of colorectal cancer due to marked cohort effects in southern Netherlands.

Liza N van Steenbergen1, Valery E P P Lemmens, Marieke J Louwman, Jan Willem A Straathof, Jan-Willem W Coebergh.   

Abstract

In preparation for any type of forthcoming colorectal cancer (CRC) mass screening we examined trends in CRC incidence and mortality according to sex, subsite and age in southern Netherlands. Population-based data from the Eindhoven Cancer Registry during the period 1975-2004 were used. Age-period-cohort analyses were performed to investigate possible aetiologic, diagnostic or therapeutic origins of the trends. Age-adjusted (European Standardized Rates) incidence rates for colon cancer increased since 1975 from 23 in 100 000 for both sexes to about 38 in 100 000 for males and 30 in 100 000 for females in 2004. Incidence of rectal cancer remained relatively stable at about 25 in 100 000 males and 15 in 100 000 females. The incidence of CRC increased for male patients from birth cohorts between 1900 and 1955 (P=0.010), especially in left-sided colon cancer in the younger birth cohorts [RR1900: 0.8 (95% confidence interval, CI: 0.6, 1.0), RR1960: 1.6 (95% CI: 0.9, 2.8), reference: 1910-1919]. For women a similar, although weaker increase in CRC incidence was found. Mortality rates for CRC started to decrease in 1975, more pronounced for rectal than for colon cancer. The relative risk for dying in men with CRC decreased from 1.3 (95% CI: 1.0, 1.6) in the 1900 birth cohort to 0.1 (95% CI: 0.1, 0.4) in the 1960 birth cohort, reference 1910-1919 birth cohort. The increasing incidence and decreasing mortality in CRC is largely affected by birth cohort effects. Changes in CRC incidence are likely to be attributed to lifestyle factors and decreasing mortality is due to earlier detection and improved treatment, especially among younger patients.

Entities:  

Mesh:

Year:  2009        PMID: 19337062     DOI: 10.1097/CEJ.0b013e32831362e7

Source DB:  PubMed          Journal:  Eur J Cancer Prev        ISSN: 0959-8278            Impact factor:   2.497


  7 in total

Review 1.  Addressing sexual dysfunction in colorectal cancer survivorship care.

Authors:  Jennifer C Averyt; Patricia W Nishimoto
Journal:  J Gastrointest Oncol       Date:  2014-10

2.  Large variation between hospitals in follow-up for colorectal cancer in southern Netherlands.

Authors:  L N van Steenbergen; I H J T de Hingh; H J T Rutten; M C M Rijk; R G Orsini; J W W Coebergh; V E P P Lemmens
Journal:  Int J Colorectal Dis       Date:  2013-04-28       Impact factor: 2.571

3.  Miss rate of colorectal cancer at CT colonography in average-risk symptomatic patients.

Authors:  P C G Simons; L N Van Steenbergen; M T De Witte; M L G Janssen-Heijnen
Journal:  Eur Radiol       Date:  2012-10-20       Impact factor: 5.315

4.  Use of age-period-cohort analysis in cancer epidemiology research.

Authors:  Caitlin C Murphy; Yang Claire Yang
Journal:  Curr Epidemiol Rep       Date:  2018-10-03

5.  The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study.

Authors:  Daniel J Lips; Boukje Koebrugge; Gerrit Jan Liefers; Johannes C van de Linden; Vincent T H B M Smit; Hans F M Pruijt; Hein Putter; Cornelis J H van de Velde; Koop Bosscha
Journal:  BMC Surg       Date:  2011-05-11       Impact factor: 2.102

6.  Deletion of chromosome 4q predicts outcome in stage II colon cancer patients.

Authors:  R P M Brosens; E J T H Belt; J C Haan; T E Buffart; B Carvalho; H Grabsch; P Quirke; M A Cuesta; A F Engel; B Ylstra; G A Meijer
Journal:  Cell Oncol (Dordr)       Date:  2011-06-30       Impact factor: 6.730

7.  The global, regional, and national burden of colorectal cancer and its attributable risk factors in 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017.

Authors: 
Journal:  Lancet Gastroenterol Hepatol       Date:  2019-10-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.